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Introduction {#sec1}
============

Aging is a complex multifactorial biological process manifested by a gradual decline of normal physiological functions in a time-dependent manner. The accumulation of senescent cells in aged tissues has been recognized as one of the most important common denominators of aging ([@bib32]). Mesenchymal stromal cells (MSCs) are extremely important adult stem cells for tissue homeostasis, regeneration, and repair. Despite their importance, it should be noted that MSCs are particularly sensitive to aging and age-related diseases, due to their central integration in the body ([@bib2]). In fact, the regenerative capacity of bone marrow MSCs deteriorates after 30 years old ([@bib9]), and their deterioration has been recognized as an important hallmark of aging ([@bib5], [@bib32]). Reciprocally, MSC senescence contributes to the pathogenesis of age-related diseases, such as osteoporosis and osteoarthritis ([@bib43]). Multiple signaling pathways leading to cellular senescence including p53/p21, p16/RB, and Akt/mTOR have been implicated in MSC senescence, which cause permanent cell cycle withdrawal and irreversible damage in very old MSCs ([@bib22], [@bib29], [@bib54], [@bib56]). However, unlike a static endpoint, senescence reflects a series of progressive and phenotypically diverse cellular states acquired after the initial growth decline ([@bib5], [@bib51], [@bib56]). A deeper understanding of the molecular mechanisms underlying the multi-step progression of MSC senescence and the link between MSC senescence and organism aging may lead to new therapeutic strategies for age-related diseases.

One striking characteristic of senescent cells is the large-scale alteration of genome architecture. For instance, in oncogene-induced senescence in fibroblasts, accumulation of constitutive heterochromatin and a dramatic rearrangement of heterochromatin into foci have been well documented ([@bib25], [@bib40]). In contrast, a loss of heterochromatin has been described in replicative senescence and premature aging (progeroid) syndromes ([@bib14], [@bib23], [@bib34]). The disparate nuclear phenotypes that accompany the different stress responses might be simply explained by the differences between acute and chronic senescence models ([@bib11]). Although the physiological function and molecular mechanism underlying the heterochromatin reorganization during senescence is still elusive, it should be noted that recent study demonstrated that MSCs derived from *WRN* null (−/−) embryonic stem cells displayed a pronounced senescence phenotype, which was attributed to disorganized heterochromatin ([@bib57]), raising a possibility that the unique and organized change of heterochromatin landscape functions as a protective mechanism against cellular senescence. Heterochromatin is characterized by typical post-translational modifications on histones, which have been postulated to be one of the mechanisms to facilitate the folding of heterochromatin into highly condensed structures ([@bib4], [@bib10], [@bib12], [@bib52], [@bib58]). These regions of compacted and transcriptionally repressive chromatin are critical for diverse aspects of nuclear biology, including the regulation of gene expression, the transcriptional silencing of genomic repeats, DNA repair, and the maintenance of genome stability ([@bib7]). Methylation of histone H3 at lysine 9 has a well-recognized role in the establishment and maintenance of heterochromatin structure ([@bib4], [@bib52], [@bib58]). SUV39H1, the first-described H3K9 methyltransferase, has been associated with oncogene-induced senescence and pathological aging process ([@bib6], [@bib44]); however, it is still unclear whether SUV39H1 regulates physiological aging. On the other hand, the steady state of methylation at H3 lysine 9 is dictated by the balance between addition and removal of methyl groups, which is achieved by a reciprocal action between lysine methyltransferases (KMTs) and histone demethylases (KDMs) ([@bib38]). Indeed, several recent studies have provided experimental evidence that KDMs are involved in the longevity regulation in *Caenorhabditis elegans* ([@bib26], [@bib35], [@bib47]), indicating the potential role of KDMs in cellular senescence and organism aging.

H3K9 demethylation is mainly catalyzed by Fe(II)- and α-ketoglutarate-dependent JmjC-domain-containing proteins, including the JMJD1/KDM3 family, JMJD2/KDM4 family, and PHF8/KDM7B ([@bib37]). In this study, we identify two conserved H3K9 KDMs, KDM3A and KDM4C, that regulate heterochromatin reorganization to restrain DNA damage and progression of MSC senescence via transcriptionally activating condensin components *NCAPD2* and *NCAPG2*. Decline in KDM3A and/or KDM4C leads to aggravated MSC senescence and bone aging in mice and is significantly correlated with chronological aging of MSCs in human. Our finding thus unveils a protective role of KDM-mediated heterochromatin reorganization in stem cells, which may provide potential targets for the diagnosis and intervention of age-related diseases.

Results {#sec2}
=======

MSC Senescence Is Accompanied by Heterochromatin Reorganization {#sec2.1}
---------------------------------------------------------------

To experimentally assess MSC senescence *in vitro*, we established a replicative senescence model using either human bone marrow stromal cells (hBMSCs) or human umbilical cord-derived stromal cells (hUCMSCs). Late passage hMSCs presented typical phenotypes of cellular senescence, including increased β-galactosidase (SA-β-gal) activity, reduced colony forming ability, loss of proliferative potential, and upregulation of p21^WAF1^ ([Figure S1](#mmc1){ref-type="supplementary-material"}A). To further evaluate the dynamic change of heterochromatin and H3K9 methylation accompanied by hMSC senescence, we focused on hUCMSCs, which sustains rapid multiplication until p16-p18 ([@bib13]). A gradual aging process in hUCMSCs was demonstrated by progressively increased SA-β-gal--positive cells ([Figure 1](#fig1){ref-type="fig"}A). In consistence with the previous reports, the expression levels of H3K9 methylation and heterochromatin mark HP1-γ were dramatically reduced at the final stage of cellular senescence (p26), at which more than 85% of cells reached a senescence state ([Figures 1](#fig1){ref-type="fig"}A and 1B, p26). Of note, although the expression levels of H3K9 methylation were eventually lost, there was a mild induction of these repressive heterochromatin marks at the early stage of senescence (p10-p16) at which only small amount of cells exhibited senescent features ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}B). The induction of heterochromatin marks was further validated by immunofluorescent staining using constitutive heterochromatin mark H3K9me3 and a centromere-specific heterochromatin mark CENPA ([Figure 1](#fig1){ref-type="fig"}C). In the young hUCMSCs (p6), heterochromatin was mainly localized underneath the nuclear membrane. On senescence entry, heterochromatin was markedly increased and reorganized into condensed heterochromatin foci (p16). Collectively, these data demonstrate that MSC senescence is accompanied by heterochromatin reorganization.Figure 1MSC Senescence Is Accompanied by Heterochromatin ReorganizationThree hUCMSCs lines (hUC009, hUC011, hUC013) were used for serial passaging and characterized with various senescence markers.(A)Morphology and β-Gal staining (scale bar = 100μm) in serial passage replicative senescence cell model with hUCMSCs. Quantification is shown at the right panel; data are presented as the mean ± SEM. \*\*\*p \< 0.01 (t test, n = 3).(B) Representative Western blot showing the expression levels of senescence marker genes and heterochromatin marks along with hUCMSCs aging; experiments were repeated three times.(C) Representative images of immunofluorescence staining with H3K9me3 (green) and CENPA (red) in hUCMSCs at passage 6 and 16 (scale bar = 10μm). Experiments were repeated at least three times using three different hUCMSCs lines.(D) Representative images of immunofluorescence staining of KDM3A or KDM4C and H3K9me2/3 in hUCMSCs at p7 and p16 (scale bar = 10μm). Experiments were repeated at least three times using three different hUCMSCs lines.

Identification of H3K9 Demethylases KDM3A and KDM4C that Are Potentially Involved in MSC Senescence {#sec2.2}
---------------------------------------------------------------------------------------------------

Post-translational modifications of histones such as methylation and acetylation are central in the regulation of heterochromatin structure. To investigate the potential roles of histone modification in heterochromatin reorganization and MSC senescence, we profiled the expression of histone modifying enzymes using both replicative senescence model (hBMSCs and hUCMSCs) and chronological aging model (rat primary young *Vs* old BMSCs) ([Figure S1](#mmc1){ref-type="supplementary-material"}C). The screening results showed that the mRNA expression levels of KDM3A, KDM4C, and KDM5C were consistently upregulated, whereas *SUV39H1* was consistently downregulated in the three models ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2D). Of note, both KDM3A and KDM4C and SUV39H1 target on H3K9 methylation. We decided to focus on the two H3K9 KDMs, because the role of KDMs in stem cell senescence has not been characterized. The immunofluorescent staining and Western blot revealed that both KDM3A and KDM4C were readily upregulated at the early stage of senescence when heterochromatin is reorganized ([Figures 1](#fig1){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}E).

To further investigate the potential role of KDM3A and KDM4C in heterochromatin reorganization and MSC senescence, we knocked down *KDM3A* or *KDM4C* using shRNA ([Figure S3](#mmc1){ref-type="supplementary-material"}A) in the early passage hUCMSCs (p6). Our results showed that suppression of *KDM3A* or *KDM4C* induced a rapid onset of cellular senescence (p8) as demonstrated by increased β-gal activity, reduced colony formation, and increased expression of *p21* and *p15* in hUCMSCs ([Figures 2](#fig2){ref-type="fig"}A and 2B). Of particular interest, knockdown of *KDM3A* or *KDM4C* provoked a robust increase of γ-H2AX and 53BP1 foci, indicating an accumulation of DNA damage response (DDR) ([Figure 2](#fig2){ref-type="fig"}C). To answer the question of whether the effects of KDM3A and KDM4C on cellular senescence and DDR are related to their function as H3K9 demethylase, we used IOX1, a specific JmjC histone demethylase inhibitor, to treat hUCMSCs at p6-p8. In corroboration with the knockdown data, IOX1 treatment suppressed cell proliferation, increased β-gal activity, and enhanced DDR in a dose-dependent manner ([Figures 2](#fig2){ref-type="fig"}D--2F, [S3](#mmc1){ref-type="supplementary-material"}B, and S3C). These results suggest that KDM3A and KDM4C protect MSCs from cellular senescence and DDR, the effect of which is related to their histone demethylase activity.Figure 2Suppression of H3K9 Demethylases KDM3A and KDM4C Induces DNA Damage and Accelerates Cellular Senescence in hUCMSCsTwo different hUCMSCs lines (hUC009, hUC013) were used for knockdown or IOX experiments.(A) Representative images of colony formation and β-Gal staining (scale bar = 100μm) in hUCMSCs treated with control shRNA or shRNAs targeting *KDM3A* or *KDM4C*. The cells were selected by ZsGreen positivity after lentiviral transduction and grew for two more passages. Quantification of β-Gal staining is shown at the right; data are presented as the mean ± SEM. \*\*\*p \< 0.001 (t test: n = 3).(B) RT-qPCR assay showing the expression levels of *KDM3A*, *KDM4C, p15,* and *p21* after shRNA treatment; data are presented as the mean ± SEM. \*\*p \< 0.01; \*\*\*p \< 0.001 (t test: n = 3).(C) Representative images (scale bar = 5μm) and quantification of 53BP1, γ-H2AX foci in hUCMSCs transduced with lentiviral particles carrying shKDM3A-1, shKDM4C-1, or control shRNA. Quantification data are presented as mean ± SEM of values from three independent experiments with triplicate wells analyzed on 6--8 cells/field from five different fields. \*\*\*p \< 0.001 (t test).(D) MTT assay of hUCMSCs (p6) treated with different concentrations of IOX1 or DMSO for 72 h. Data are presented as the mean ± SEM of values from three independent experiments; \*\*p \< 0.01, IOX70μM compared with control; \#\#p \< 0.01, IOX100μM compared to control group (t test).(E) Quantification of β-Gal staining in hUCMSCs (p7) treated with different concentrations of IOX1 (20, 50, 70, and 100 μM). Data are presented as the mean ± SEM. \*p \< 0.05; \*\*p \< 0.01 (one-way ANOVA, n = 3).(F) Quantification of 53BP1 and γ-H2AX foci in hUCMSCs (p6) treated with different concentration IOX1 (20, 50, 70, and 100 μM) and DMSO control. Quantification is shown at the right; mean ± SEM of values from three independent experiments with triplicate wells analyzed on 6--8 cells/field from five different fields. \*p \< 0.05; \*\*p \< 0.01 (one-way ANOVA).

KDM3A and KDM4C Regulate Condensin Complex Components NCAPD2 and NCAPG2 via Their Demethylase Activity {#sec2.3}
------------------------------------------------------------------------------------------------------

To elucidate the mechanism underlying the regulatory effect of KDM3A and KDM4C on MSC senescence, we analyzed the KDM3A- or KDM4C-dependent transcriptional program using RNA-seq in MSCs. Manipulation of *KDM3A* or *KDM4C* led to a consistent change in chromosome organization genes, in particular chromosome condensation genes ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B, GEO: [GSE133098](ncbi-geo:GSE133098){#intref0010}). Interestingly, among the chromosome condensation genes, we have identified that various components of the condensin complex I and II are consistently downregulated in *KDM3A*- or *KDM4C*-knockdown hUCMSCs or upregulated in *KDM3A* or *KDM4C*-overexpressing hUCMSCs ([Figures 3](#fig3){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}B). We decided to focus on *NCAPD2* and *NCAPG2*, the major components of condensin I and condensin II, respectively, which are unanimously regulated by KDM3A and KDM4C. Our real-time PCR and Western blot showed that siRNA knockdown of either *KDM3A* or *KDM4C* reduced the expression levels of both NCAPD2 and NCAPG2 ([Figures 3](#fig3){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}C). Moreover, the binding of KDM3A and KDM4C on the promoter of *NCAPD2* was significantly downregulated, whereas the occupancy of corresponding H3K9me3 and H3K9me2 was significantly upregulated in knockdown hUCMSCs ([Figure 3](#fig3){ref-type="fig"}C). In addition, inhibition of H3K9 demethylase activity by IOX1 reduced the expression levels of NCAPD2 and NCAPG2 ([Figure 3](#fig3){ref-type="fig"}D). IOX1 also reduced the expression level of Lamin B1 and increased the expression level of p53, supporting the senescence-inducing property of IOX1. The regulatory effect of IOX1 was attributed to the enzyme inhibitory function, as IOX1 increased the enrichment of H3K9me2 and H3K9me3 on *NCAPD2* promoter ([Figure 3](#fig3){ref-type="fig"}E). Altogether, these data clearly indicate that KDM3A and KDM4C function as positive transcriptional regulators of condensin components via their H3K9 demethylase activity. As a first step to identify the potential mechanism underlying condensin-mediated effects, quantitative ChIP-PCR was used to determine the recruitment of NCAPD2 on repetitive DNA sequences, at which heterochromatin enriches. Our results showed that the binding of NCAPD2 on replicative DNA sequences was significantly reduced in *KDM3A-* or *KDM4C*-knockdown cells ([Figure 3](#fig3){ref-type="fig"}F), suggesting that KDM-mediated regulation of condensin might be critical for stabilizing the heterochromatin structure during senescence.Figure 3KDM3A and KDM4C Transcriptionally Regulate Condensin Components NCAPD2 and NCAPG2 via Their Demethylase Activity(A) Heatmap showing the global downregulation and upregulation of chromosome condensation genes in siKDM3A-/siKDM4C-knockdown (hUC009) or KDM3A-/KDM4C-overexpressing hUCMSCs (hUC013) compared with their relative control hUCMSCs.(B) Representative Western blot showing that the expression levels of NCAPD2 and NCAPG2 are downregulated in *KDM3A*- or *KDM4C*-knockdown cells (hUC009). Data are presented as the mean ± SEM. \*\*p \< 0.01; \*\*\*p \< 0.001 (t test).(C) ChIP-qPCR showing the enrichment of H3K9me2, 3, *KDM3A* (siKDM3A-1+siKDM3A-3), or *KDM4C* (siKDM4C-1+siKDM4C-3) on *NCAPD2* promoters relative to IgG enrichment after siRNA treatment. Data are presented as the mean ± SEM. \*p \< 0.05; \*\*p \< 0.01 (t test, n = 3).(D) Representative Western blot showing the expression of senescence markers and NCAPD2 and NCAPG2 in hUCMSCs (p6-p8) treated with different concentration IOX1 (20, 50, 70, and 100μM). Experiments were repeated three times with two hUCMSCs lines (hUC009, hUC013). Data are presented as the mean ± SEM. \*p \< 0.05; \*\*p \< 0.01 (one-way ANOVA).(E) ChIP-qPCR showing increased enrichment of H3K9me1, 2, and3 on the representative *NCAPD2* promoter relative to IgG enrichment in 70μM IOX1-treated hUCMSCs. Data are presented as the mean ± SEM. \*\*p \< 0.01; \*\*\*p \< 0.001 (t test: n = 3).(F) ChIP-qPCR showing the enrichment of NCAPD2 on several repetitive DNA sequences loci in control- or *KDM3A* (siKDM3A-1+siKDM3A-3) or *KDM4C* (siKDM4C-1+siKDM4C-3) siRNA-treated hUCMSCs, data are presented as the mean ± SEM, \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001 (t test: n = 3).

KDM3A and KDM4C Induce Heterochromatin Reorganization to Restrain DNA Damage Response in Doxorubicin-Induced Senescence {#sec2.4}
-----------------------------------------------------------------------------------------------------------------------

The finding that suppression of KDM3A and KDM4C leads to increased DDR raises the possibility that KDM3A and KDM4C function as a protective mechanism against DNA damage during cellular senescence. To establish a direct link between KDM3A/KDM4C and DDR in senescent cells, we applied a DNA damage--induced acute senescence model in hUCMSCs using [Doxorubicin](http://Doxorubicin){#intref0015} (DOX). DOX treatment induced a gradual increase in KDM3A and KDM4C level peaked at 10--12 h, which thereafter decreased at 24 h and returned to virtually background level at 48 h. Of note, the kinetics of heterochromatin marks H3K9me3 and HP1γ, and condensin components NCAPD2 and NCAPG2 were consistent with the KDMs upon DOX treatment ([Figure 4](#fig4){ref-type="fig"}A), suggesting DOX treatment induces a heterochromatin reorganization process, which may be associated with KDM3A and KDM4C. In corroboration with the Western blot result, the immunofluorescent staining showed that heterochromatin mark gradually increased, which peaked at 10 h and decreased thereafter. Accordingly, 53BP1 and γ-H2AX foci were induced at 24 h, which stochastically distributed throughout the nucleus, and maximized around 48 h after DNA damage ([Figures 4](#fig4){ref-type="fig"}B and 4C). The sequential inductive effect on heterochromatin reorganization and DDR upon DOX treatment suggests a surveillance mechanism by heterochromatin rearrangement. In fact, knockdown of *KDM3A* and *KDM4C* or treatment with IOX1 markedly aggravated DOX-induced DDR and cellular senescence ([Figures 4](#fig4){ref-type="fig"}D, [S5](#mmc1){ref-type="supplementary-material"}A, and S5B). By contrast, overexpression of *KDM3A* or *KDM4C* significantly reduced the number of DOX-induced 53BP1 and γ-H2AX foci and degree of cellular senescence as demonstrated by decreased β-gal activity and a dramatic downregulation of p21^WAF1^ ([Figures 4](#fig4){ref-type="fig"}E, [S5](#mmc1){ref-type="supplementary-material"}C, and S5D). In addition, overexpression of condensin I complex component *NCAPD2* alone significantly rescued DOX-induced DDR and cellular senescence, albeit at a lower level compared with *KDM3A* or *KDM4C* overexpression ([Figures 4](#fig4){ref-type="fig"}E, [S5](#mmc1){ref-type="supplementary-material"}C, and S5D). The protective role of KDM3A and KDM4C is related to heterochromatin reorganization, as overexpression of *KDM3A*/*KDM4C* or *NCAPD2* promoted heterochromatin reorganization as indicated by H3K9me2/3 staining ([Figures S5](#mmc1){ref-type="supplementary-material"}C and S5D). The role of KDM3A/KDM4C and NCAPD2 in chromatin reorganization was further illustrated by Transmission Electron Microscope (TEM) analysis or immunofluorescent staining in *KDM3A*/*KDM4C-* or *NCAPD2*-overexpressing cells. As shown in [Figure S6](#mmc1){ref-type="supplementary-material"}A, *KDM3A* or *KDM4C* overexpression induced chromosome condensation in the nuclear. Similarly, overexpression of *NCAPD2* directly promoted heterochromatin reorganization as indicated by an increase of H3K9me3 positive foci ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Collectively, these results clearly demonstrate a protective role of KDM3A and KDM4C in DNA damage--induced senescence through induction of heterochromatin reorganization.Figure 4Doxorubicin Induces Heterochromatin Reorganization and DNA Damage ResponseTwo hUCMSCs lines (hUC009, hUC013) were used for Doxorubicin-induced cellular senescence model.(A) Early passage hUC-MSCs (p6-7) were treated with Doxorubicin for 48 h. Representative Western blot showing the expression levels of KDM3A, KDM4C, heterochromatin marks, NCAPD2, NCAPG2, and senescence marks at different time points (0--48 h) after Doxorubicin treatment.(B) Representative immunofluorescence images of 53BP1 or γ-H2AX foci and H3K9me2/3 staining (scale bar = 5μm) in hUCMSCs treated with Doxorubicin for different time points.(C) Quantification of 53BP1 or γ-H2AX and H3K9me2/3 immunofluorescence staining in hUCMSCs treated with Doxorubicin for different time points (CTCF, corrected total cell fluorescence). Data are presented as mean ± SEM of values from three different experiments with triplicate wells analyzed on 6--8 cells/field from five different fields; \*p \< 0.05; \*\*p \< 0.01, 53BP1, γ-H2AX compared with control group, \#p \< 0.05; \#\#p \< 0.01, H3K9me2/3 compared with control group (Wilcoxon/Mann-Whitney test).(D) Representative images and quantification of 53BP1 and γ-H2AX immunofluorescence staining (scale bar = 5μm) in Doxorubicin-treated hUCMSCs transfected with scrambled siRNAs or siRNA mixtures (siKDM3A-1 + siKDM4C-3). Data are presented as mean ± SEM of values from three different experiments with triplicate wells analyzed on 6--8 cells/field from five different fields; \*\*p \< 0.01; \*\*\*p \< 0.001 (t test).(E) Representative images and quantification of β-Gal staining (scale bar = 100μm) in control group or Doxorubicin-treated hUCMSCs transfected with Vector plasmid or *KDM3A*, *KDM4C,* or *NCAPD2* plasmid.Data are presented as the mean ± SEM. \*p \< 0.05; \*\*p \< 0.01 (t test, n = 3).

Dynamic Change of KDM3A/KDM4C and Condensin Complex Components during Bone Aging in Mice {#sec2.5}
----------------------------------------------------------------------------------------

Having established the role of KDM3A and KDM4C in MSC senescence *in vitro*, we asked whether the two H3K9 KDMs are related to heterochromatin reorganization of MSCs during aging *in vivo*. For this purpose, we established ovariectomized (OVX) rat model, which is a well-established model to study bone aging process. Successful OVX was validated at sacrifice, using uterus weight, bone CT, and morphometric indexes ([Figures S7](#mmc1){ref-type="supplementary-material"}A--S7C). We then isolated rat bone marrow MSCs (rBMSCs) at different time points starting from 3 weeks to 12 weeks after OVX and determined the molecular changes and heterochromatin marks indicative of cellular senescence. The result illustrated a dramatic reduction of H3K9 methylation in rBMSCs collected at 9--12 weeks, at which the osteoporosis was utmost severe ([Figure 5](#fig5){ref-type="fig"}A). Of note, the kinetics of *Kdm3a* and *Kdm4c* expression peaked at both 6 weeks and 12 weeks ([Figures 5](#fig5){ref-type="fig"}A and 5B) recapitulating the expression dynamics in replicative senescence model ([Figure S2](#mmc1){ref-type="supplementary-material"}E). Importantly, a gradual increase of senescence markers including *p15*, *p19*, and *p27* was detected in rBMSCs along with disease development, indicating deterioration of rBMSCs along with bone aging process ([Figure 5](#fig5){ref-type="fig"}C). In addition, the expression levels of *Ncapd2* and *Ncapg2* reached the peak at 6 weeks, which was in line with *Kdm3a* and *Kdm4c* upregulation and decreased thereafter ([Figure 5](#fig5){ref-type="fig"}C), emphasizing the association between *Kdm3a*/*Kdm4c* and condensin complexes at the early stage of bone aging.Figure 5Dynamic Change of KDM3A and KDM4C in OVX Rat Model(A) Western blot analysis of *Kdm3a*, *Kdm4c*, and H3K9 methylation in BMSCs derived from OVX rat model (total n = 22; Sham, n = 4; OVX3w, n = 4; OVX6w, n = 4; OVX9w, n = 5; OVX12w, n = 5). The experiments were repeated for three times.(B) The quantification analysis of Western blot results of *Kdm3a*, *Kdm4c*, and H3K9me3 show two peaks of *Kdm3a* and *Kdm4c* (n = 22). \*p \< 0.05, change of *Kdm3a* expression compared with sham; p \< 0.05, change of *Kdm4c* expression compared with sham; \#p \< 0.05, change of H3K9me3 compared with sham (Wilcoxon/Mann-Whitney test).(C) RT-qPCR assay of *Ncapd2*, *Ncapg2,* and several cell cycle inhibitor genes in BMSCs derived from OVX rat model.Data are presented as mean ± SEM. \*p \< 0.05 (Wilcoxon/Mann-Whitney test, n = 22).

Deficiency of *Kdm3a* Leads to MSC Senescence and Bone Aging in Mice {#sec2.6}
--------------------------------------------------------------------

The *Kdm3a*^−/−^ mice have defects in sex determination, lipid metabolism, and spermatogenesis ([@bib28], [@bib31], [@bib50]); however, the relationship between *Kdm3a* deficiency and aging has not been investigated. In this study, we took advantage of *Kdm3a* knockout mice to evaluate the effect of *Kdm3a* deficiency on bone aging ([Figure S7](#mmc1){ref-type="supplementary-material"}D). We collected bone tissues from WT and KO mice at different ages and found that although no difference exists between WT and KO young mice (2 month), KO mice at 6 months old exhibited evident bone aging phenotype ([Figure 6](#fig6){ref-type="fig"}A). The expression levels of senescence markers p53, p21, and p16 were dramatically increased, whereas the expression of PCNA was significantly decreased in KO bones. In addition, senescence nuclear markers such as Lamin B1, H3K9me3, and H3K27me3 and condensin components were dramatically downregulated in KO bones, indicating the correlation between bone aging and heterochromatin destruction *in vivo* ([Figures 6](#fig6){ref-type="fig"}B and 6C). Of note, the expression of Suv39h1 was slightly increased in KO mice. To further correlate these changes with BMSCs, we isolated primary BMSCs from WT and KO mice. Our results showed that condensin components were significantly downregulated in KO BMSCs compared with WT BMSCs. In contrast, the expression levels of senescence genes such as *p53*, *p21*, and *Gadd34* were significantly upregulated in KO BMSCs ([Figure S7](#mmc1){ref-type="supplementary-material"}E). Moreover, when challenged with DOX, KO BMSCs elicited a much enhanced DDR as illustrated by increased expression of 53BP1 and p21 ([Figure S7](#mmc1){ref-type="supplementary-material"}F). The specificity of the KO was validated by overexpressing *Kdm3a* in KO BMSCs, which showed that overexpression of *Kdm3a* completely rescued aggravated cellular senescence and increased DDR induced by DOX in KO cells ([Figures S7](#mmc1){ref-type="supplementary-material"}G and S7H). In addition, overexpression of *Ncapd2* alleviated the DOX-induced cellular senescence and DDR in KO BMSCs ([Figures 6](#fig6){ref-type="fig"}D and 6E). Altogether, these results strongly indicate that *Kdm3a* deficiency aggravates DNA damage and cellular senescence in BMSCs, which eventually contributes to the bone aging phenotype in mice.Figure 6Deficiency of *Kdm3a* Leads to MSC Senescence and Bone Aging in Mice(A) The representative three-dimensional reconstructed images of distal femur in a 6-month-old female *Kdm3a*^−/−^ mice and WT mice by CT scanner. Quantification of morphometric parameters including bone volume fraction (BV/TV), trabecular number (Tb.N, 1/mm), and trabecular separation (Tb.Sp, mm) are shown at right. Data are presented as the mean ± SEM, \*\*p \< 0.01 (t test, n = 6).(B) Western blot assay showing the expression of senescence markers p16, p21, p53, and heterochromatin markers H3K9me3 and H3K27me3 in bone tissues collected from 6-month-old *Kdm3a*^−/−^ KO mice (n = 6) and WT mice (n = 6). Experiments were repeated three times, \*p \< 0.05; \*\*p \< 0.01 (Wilcoxon/Mann-Whitney test).(C) RT-qPCR assay showing the reduction of condensin components in bone tissues collected from 6-month-old *Kdm3a*^*−/−*^ KO mice. Data are presented as the mean ± SEM, \*p \< 0.05; \*\*p \< 0.01 (t test, n = 3).(D) Representative images and quantification of β-Gal staining (scale bar = 100μm) show Ncapd2 rescues Doxorubicin-induced cellular senescence in KO BMSCs. Quantification data represents mean ± SEM of values from three independent experiments with three pairs of WT and KO mMSCs. \*p \< 0.05; \*\*p \< 0.01 (t test, n = 3).(E) Representative images and quantification of γ-H2A.X and p21 immunofluorescence staining (scale bar = 5μm). Overexpression of *ncapd2* in KO BMSCs completely rescues Doxorubicin-induced DNA damage and heterochromatin destruction. Quantification data are presented as mean ± SEM of values from three different experiments with three pairs of WT and KO mMSCs. In each experiment, cells were derived from triplicate wells and analyzed on 6--8 cells/field from five different fields. \*\*p \< 0.01; \*\*\*p \< 0.001 (t test, n = 3).

The Expression Levels of KDMs and Condensin Components Are Inversely Correlated with Human Aging {#sec2.7}
------------------------------------------------------------------------------------------------

Previous studies on gene expression analysis of young versus old human BMSCs have revealed large amounts of age-associated molecular changes related to MSC adhesion, cell cycle regulation, migration, and cytokine secretion ([@bib8], [@bib53]). However, whether MSC aging is associated with a global change of genes involved in chromosome organization is unknown. In this study, we asked whether KDM3A/KDM4C and condensin components could be related to physiological aging in human stem cells. We first compared the expression levels of KDM3A/KDM4C, condensin components, and heterochromatin marks in primary BMSCs derived from nine young (13- to 32-year-old) and five old (52- to 61-year-old) individuals ([Figure 7](#fig7){ref-type="fig"}A). Our Western blot result showed a marked downregulation of KDM3A and KDM4C protein associated with a decrease in H3K9me3 and PCNA in BMSCs derived from old individuals. Importantly, the expression of NCAPG2 and NCAPD2 was dramatically decreased in aged BMSCs as well. It should be noted that the expression of SUV39H1 did not change in old BMSCs. To confirm the correlation of *KDM3A/KDM4C* and *NCAPD2/NCAPG2* with aging, we examined publically available MSC gene expression datasets (GEO: [GSE39540](ncbi-geo:GSE39540){#intref0020}). GSE dataset analysis revealed that the expression levels of *KDM3A*, *KDM4C*, *NCAPD2,* and *NCAPG2* were negatively correlated with human aging ([Figure 7](#fig7){ref-type="fig"}B). Taken together, these data clearly reveal that KDM3A and KDM4C are negatively correlated with stem cell aging in human.Figure 7Expression Levels of *KDM3A/KDM4C and NCAPD2/NCAPG2* Are Inversely Correlated with Human Aging(A) Western blot assay showing the expression levels of KDM3A, KDM4C, heterochromatin marks, and condensin components are globally reduced in old hBMSCs compared with young hBMSCs. Human bone marrow MSCs from 14 healthy individuals (Male, Asian, age range from 13 to 61 years) were cultured for three passages and used for further analysis. Quantification of KDM3A and KDM4C is shown at right. Data are presented as the mean ± SEM, \*p \< 0.05 (Wilcoxon/Mann-Whitney test).(B) Negative correlations between *KDM3A*, *KDM4C*, *NCAPD2*, and *NCAPG2* (y axis) and age (x axis) in human MSCs samples (n = 60, age range from 19 to 84 years) (GEO: [GSE39540](ncbi-geo:GSE39540){#intref0030}).

Discussion {#sec3}
==========

Although heterochromatin reorganization is observed during cellular senescence, the physiological function of this unique epigenetic change is still ill defined. In this study, we have unveiled that KDM3A and KDM4C regulate condensin-dependent heterochromatin reorganization to restrain DDR during MSC senescence. Deficiency of *Kdm3a* leads to accelerated MSC senescence and premature bone aging in mice. From a clinical perspective, reduced expression of *KDM3A/KDM4C* or condensin component genes *NCAPD2* and *NCAPG2* can be utilized as indicators for aging.

Significant chromatin structural changes occur during physiological aging and cellular senescence, which include global histone loss, alternation of epigenetic landscapes, loss of heterochromatic regions, and large-scale chromatin rearrangements([@bib15], [@bib20], [@bib32], [@bib39]). However, it is interesting to note that different senescence models may have disparate and unique chromatin changes. We have illustrated that MSC replicative senescence is accompanied by heterochromatin reorganization at the early stage and heterochromatin loss at the final stage. In particular, upon senescence entry, a spatial reorganization of heterochromatin structure is manifested by redistribution and condensation of heterochromatin from nuclear membrane to nucleoplasm ([Figure 1](#fig1){ref-type="fig"}C). The dynamic change of heterochromatin is also observed in DOX-induced senescence model, which displays a gradual heterochromatin reorganization followed by a rapid heterochromatin destruction after genotoxic treatment ([Figures 4](#fig4){ref-type="fig"}A and 4B). In line with the cell models, the stage-dependent change of heterochromatin has been recapitulated in OVX-induced bone aging model, which demonstrates a dynamic change of heterochromatin marks in primary BMSCs collected at different time points along with disease progression ([Figures 5](#fig5){ref-type="fig"}A and 5B). Altogether, it is clear that a stage-dependent heterochromatin reorganization process exists in conjunction with MSC senescence, misregulation of which could be detrimental as heterochromatin perturbation has been observed in progeria syndrome ([@bib23], [@bib45], [@bib48], [@bib57]), and heterochromatin disorganization was proposed to underlie the pathogenesis of premature MSC aging in Werner syndrome ([@bib57]).

Interestingly, we have found that KDM3A and KDM4C are concomitantly upregulated along with heterochromation process at the early stage of replicative and DNA damage--induced senescence ([Figures 1](#fig1){ref-type="fig"}D and [4](#fig4){ref-type="fig"}A--4C). Knockdown or suppression of *KDM3A* and *KDM4C* downregulates chromosome organization genes, whereas overexpression of *KDM3A* and *KDM4C* induces them ([Figures 3](#fig3){ref-type="fig"} and [S4](#mmc1){ref-type="supplementary-material"}). Condensin complex is of paramount importance for chromosome assembly and compaction during mitosis and meiosis ([@bib24], [@bib36]). However, recent studies provide evidence that condensin complex might be involved in other biological processes. Previous studies have illustrated that condensins shape chromatin organization by its localization to topologically associating domain (TAD) boundaries in *Drosophila,* mouse, and human embryonic stem cells, indicating their regulatory role in chromatin high order organization in diverse interphase processes([@bib3]). In addition, condensin complex binds to promoters and enhancers and participates in gene regulation in a variety of organisms ([@bib41], [@bib42], [@bib49]). Despite of all these links, the potential role of condensin complex in the heterochromatin organization and cellular senescence had not been investigated until one recent study showed that condensin complex II subunit NCAPH2 was increased in oncogene-induced cancer cell lines ([@bib55]). In addition, overexpression of *NCAPH2* was sufficient to induce the formation of SAHF, whereas knockdown of *NCAPH2* reduced oncogene-induced cellular senescence in IMR90 fibroblasts ([@bib55]). This study raises unresolved fundamental questions of how condensin complex is induced upon senescence entry and what is the functional role of condensin complex during physiological aging. In the current study, we have unveiled that KDM3A and KDM4C induce the expression of both condensin I and II complex components at the early stage of MSC senescence via the H3K9 demethylase activity ([Figures 3](#fig3){ref-type="fig"}B--3E). Condensin complex I subunit NCAPD2 and condensin complex II subunit NCAPG2 promote heterochromatin condensation and reorganization, and overexpression of the condensin complex subunit rescues DOX-induced cellular senescence and heterochromatin destruction in *Kdm3a* KO MSCs ([Figures 6](#fig6){ref-type="fig"}D, 6E, and [S6](#mmc1){ref-type="supplementary-material"}). In addition, suppression of KDMs alleviates the recruitment of condensin on the repetitive DNA sequences ([Figure 3](#fig3){ref-type="fig"}F). Positive correlation between *KDM3A/KDM4C* and condensin components has been demonstrated in *Kdm3a* KO mice and human stem cells, which are associated with aging ([Figures 6](#fig6){ref-type="fig"}C and [7](#fig7){ref-type="fig"}). Altogether, these results suggest that condensin complex mediates the regulatory role of KDM3A and KDM4C in heterochromatin reorganization after the initial growth arrest during cellular senescence.

Activation of DDR is thought to enforce cellular senescence by imposing permanent checkpoints ([@bib16], [@bib17], [@bib18]). Although DDR and chromatin reorganization have been both causally implicated in the establishment of cellular senescence, their relationship remains largely undefined ([@bib30], [@bib33], [@bib46]). In our study, we observed that inhibition of KDM3A or KDM4C induced a striking DDR at the early stage of MSC senescence ([Figure 2](#fig2){ref-type="fig"}C). Because KDM3A and KDM4C is important for heterochromatin reorganization, we hypothesized that by hindering access of DNA damage sensors and associated DDR factors, heterochromatin can restrain DDR signaling in senescent stem cells, which functions as a protective machinery against senescence progression. To test this, we employed a genotoxic damage--induced cellular senescence model and clearly demonstrated that DOX induced a progressive heterochromatin reorganization process in advance of the activation of DDR ([Figures 4](#fig4){ref-type="fig"}A--4C). Suppression of *KDM3A* and *KDM4C* dramatically enhanced DOX-induced DDR signaling and cellular senescence ([Figures 4](#fig4){ref-type="fig"}D, [S5](#mmc1){ref-type="supplementary-material"}A, and S5B), whereas overexpression of *KDM3A/KDM4C* or condensin component attenuated the DDR and senescence ([Figures 4](#fig4){ref-type="fig"}E and [S5](#mmc1){ref-type="supplementary-material"}C), suggesting heterochromatin perturbation leads to an increase of DDR signaling in genotoxic damage--induced senescence. This assumption is further supported by the finding that *Kdm3a* KO mice that exhibit a defective condensin machinery are more sensitive to DOX-induced DDR ([Figures S7](#mmc1){ref-type="supplementary-material"}G and S7H). Heterochromatin has been reported to pose a barrier to DDR signaling ([@bib16], [@bib17], [@bib19], [@bib39]). In *Drosophila*, HP1 prevents DDR activation at chromosome ends ([@bib21]), and in mammals it modulates DDR activation ([@bib1], [@bib27]). Our results are consistent with a scenario in which heterochromatinization plays important role in restraining DDR signaling pathways, which can be achieved by both confining the access of DNA damage sensors to DNA lesions and impairing local signal amplification, thus blocking the augmentation of DNA damage and preventing senescence progression ([@bib19]). Given the established role of condensin complex in higher-order genome organization, our results strongly suggest that KDM3A and KDM4C restrain accumulation of DNA damage via condensin-mediated heterochromatin organization during senescence progression.

Another important finding from this study is that both KDM3A/KDM4C and condensin components are inversely correlated with stem cell aging in humans. We have found that the expression levels of KDM3A and KDM4C dramatically decrease in old BMSCs compared with young BMSCs, which is accompanied by a marked reduction of heterochromatin marks and NCAPD2 and NCAPG2, supporting the transcriptional regulatory role of KDM3A and KDM4C in the condensin components and other chromosome condensation genes ([Figure 7](#fig7){ref-type="fig"}). The global reduction of KDM3A, KDM4C, and core chromosome organization genes demonstrated in DOX-induced senescence model ([Figure 4](#fig4){ref-type="fig"}A) is in accordance with the marked reduction of these genes observed in aging human BMSCs. Given the established link between DNA damage and human aging, it is explicable that along with human aging, hBMSCs gradually lose KDM3A- and KDM4C-mediated heterochromatin organization machinery, which adversely makes these stem cells more susceptible to genotoxic damage. Of note, although previous study using a Werner syndrome stem cell model showed that SUV39H1 is critical for maintaining the normal heterochromatin organization, loss of which led to deregulated heterochromatin structure ([@bib57]), we did not observe any significant change of SUV39H1 in old BMSCs compared with young BMSCs ([Figure 7](#fig7){ref-type="fig"}A). Thus, it appears that distinctive epigenetic regulatory mechanisms may underlie chronological and pathological aging process.

In summary, our study has revealed a role of histone demethylases in modulating heterochromatin reorganization, which functions as a defensive mechanism against DNA damage accumulation in stem cell senescence. As chemically modifiable enzymes, KDM3A and KDM4C could be activated or deactivated to regulate stem cell senescence, thereby holding promising potentials as therapeutic targets for intervening geriatric diseases and stem cell--mediated regenerative medicine. Additionally, in view of the importance of chromosome organization in a wide variety of biological processes, the presently demonstrated critical role of H3K9 demethylases provides insights into the molecular basis underlying other physiological or pathological conditions, such as embryonic development and cancer.

Limitations of the Study {#sec3.1}
------------------------

We demonstrate that a panel of condensin components is regulated by KDM3A and/or KDM4C in MSC replicative senescence model and *Kdm3a* KO mouse model. Although our data show that the regulatory effect is attributed to the demethylase activity of KDM3A and KDM4C, we cannot exclude the possibility that other histone modifiers or transcription factors are involved in the regulatory process. Further work would also be required to definitively identify the relevant demethylase targets. Moreover, the current understanding of the link between heterochromatin reorganization and DDR in physiological condition is still elusive. Although we found that deficiency of *Kdm3a* disrupts heterochromatin reorganization and aggravates DDR during MSC senescence, additional experiments are needed to elucidate the underlying protective mechanism.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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